FlashPath

🗓 Founded 2025👥 6 employees💰 Last funded May 2026
Biotechnology Research🌐 flashpathai.com
Website LinkedIn
FlashPath connects fragmented drug safety evidence to support scientists and drug developers. Its AI-powered platform brings together large-scale preclinical, regulatory, clinical, and post-market safety data to uncover insights, identify risks earlier, and support faster, more informed decisions. By making existing evidence easier to find, connect, and use, FlashPath helps teams de-risk clinical trials, accelerate drug development, and reduce unnecessary animal testing.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in FlashPath?
FlashPath has 1 investors on record on gritt.io, including 1 early-stage backers.
When did FlashPath last raise funding?
The most recent investment in FlashPath recorded on gritt.io was in May 2026.
When was FlashPath founded?
FlashPath was founded in 2025.
What industry is FlashPath in?
FlashPath operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.